{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:49:57Z","timestamp":1793332197691,"version":"4.5.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Huntington\u2019s disease (HD) is a neurodegenerative disorder whose major symptoms include progressive motor and cognitive dysfunction. Cognitive decline is a critical quality of life concern for HD patients and families. The enzyme histone deacetylase 3 (HDAC3) appears to be important in HD pathology by negatively regulating genes involved in cognitive functions. Furthermore, HDAC3 has been implicated in the aberrant transcriptional patterns that help cause disease symptoms in HD mice. HDAC3 also helps fuel CAG repeat expansions in human cells, suggesting that HDAC3 may power striatal expansions in the\n                    <jats:italic>HTT<\/jats:italic>\n                    gene thought to drive disease progression. This multifaceted role suggests that early HDAC3 inhibition offers an attractive mechanism to prevent HD cognitive decline and to suppress striatal expansions. This hypothesis was investigated by treating Hdh\n                    <jats:sup>Q111<\/jats:sup>\n                    knock-in mice with the HDAC3-selective inhibitor RGFP966. Chronic early treatment prevented long-term memory impairments and normalized specific memory-related gene expression in hippocampus. Additionally, RGFP966 prevented corticostriatal-dependent motor learning deficits, significantly suppressed striatal CAG repeat expansions, partially rescued striatal protein marker expression and reduced accumulation of mutant huntingtin oligomeric forms. These novel results highlight RGFP966 as an appealing multiple-benefit therapy in HD that concurrently prevents cognitive decline and suppresses striatal CAG repeat expansions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-017-05125-2","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T10:58:28Z","timestamp":1500029908000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["A selective inhibitor of histone deacetylase 3 prevents cognitive deficits and suppresses striatal CAG repeat expansions in Huntington\u2019s disease mice"],"prefix":"10.1038","volume":"7","author":[{"given":"Nuria","family":"Suelves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Kirkham-McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Lahue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Gin\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"5125_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. Cell \n                           72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"5125_CR2","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JPG Vonsattel","year":"1998","unstructured":"Vonsattel, J. P. G. & DiFiglia, M. Huntington disease. J. Neuropathol. Exp. Neurol. \n                           57, 369\u2013384 (1998).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"5125_CR3","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/sj.embor.7400250","volume":"5","author":"C Landles","year":"2004","unstructured":"Landles, C. & Baters, G. P. Huntingtin and the molecular pathogenesis of Huntington\u2019s disease. Fourth in molecular medicine review series. EMBO Rep. \n                           5, 958\u2013963 (2004).","journal-title":"EMBO Rep."},{"key":"5125_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-9525(03)00074-X","volume":"19","author":"KL Sugars","year":"2003","unstructured":"Sugars, K. L. & Rubinsztein, D. C. Transcriptional abnormalities in Huntington disease. Trends Genet. \n                           19, 233\u2013238 (2003).","journal-title":"Trends Genet."},{"key":"5125_CR5","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1093\/hmg\/9.14.2197","volume":"9","author":"A McCampbell","year":"2000","unstructured":"McCampbell, A. et al. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. \n                           9, 2197\u20132202 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR6","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1126\/science.1056784","volume":"291","author":"FC Nucifora Jr.","year":"2001","unstructured":"Nucifora, F. C. Jr. et al. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science \n                           291, 2423\u20132428 (2001).","journal-title":"Science"},{"key":"5125_CR7","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/hmg\/ddr552","volume":"21","author":"A Giralt","year":"2012","unstructured":"Giralt, A. et al. Long-term memory deficits in Huntington\u2019s disease are associated with reduced CBP histone deacetylase activity. Hum. Mol. Genet. \n                           21, 1203\u20131216 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR8","doi-asserted-by":"publisher","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas, E. A. et al. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice. Proc. Natl. Acad. Sci. USA \n                           105, 15564\u201315569 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"5125_CR9","doi-asserted-by":"publisher","first-page":"5280","DOI":"10.1093\/hmg\/dds379","volume":"21","author":"H Jia","year":"2012","unstructured":"Jia, H., Kast, R. J., Steffan, J. S. & Thomas, E. A. Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntington\u2019s disease mice: implications for the ubiquitin-proteasomal and autophagy systems. Hum. Mol. Genet. \n                           21, 5280\u20135293 (2012).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.nbd.2012.01.016","volume":"46","author":"H Jia","year":"2012","unstructured":"Jia, H. et al. Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington\u2019s disease. Neurobiol. Dis. \n                           46, 351\u2013361 (2012).","journal-title":"Neurobiol. Dis."},{"key":"5125_CR11","doi-asserted-by":"publisher","first-page":"E56","DOI":"10.1073\/pnas.1415195112","volume":"112","author":"H Jia","year":"2014","unstructured":"Jia, H., Morris, C. D., Williams, R. M., Loring, J. F. & Thomas, E. A. HDAC inhibition imparts beneficial transgenerational effects in Huntington\u2019s disease mice via altered DNA and histone methylation. Proc. Natl. Acad. Sci. USA \n                           112, E56\u201364 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"5125_CR12","doi-asserted-by":"publisher","first-page":"e0152498","DOI":"10.1371\/journal.pone.0152498","volume":"11","author":"H Jia","year":"2016","unstructured":"Jia, H. et al. The Effects of Pharmacological Inhibition of Histone Deacetylase 3 (HDAC3) in Huntington\u2019s Disease Mice. PLOS One \n                           11, e0152498 (2016).","journal-title":"PLOS One"},{"key":"5125_CR13","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1523\/JNEUROSCI.5831-12.2013","volume":"33","author":"FH Bardai","year":"2013","unstructured":"Bardai, F. H. et al. Disassociation of histone deacetylase-3 from normal huntingtin underlies mutant huntingtin neurotoxicity. J. Neurosci. \n                           33, 11833\u201311838 (2013).","journal-title":"J. Neurosci."},{"key":"5125_CR14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3233\/JHD-120023","volume":"1","author":"A Giralt","year":"2012","unstructured":"Giralt, A., Saavedra, A., Alberch, J. & Perez-Navarro, E. Cognitive dysfunction in Huntington\u2019s Disease: humans, mouse models and molecular mechanisms. J. Huntingtons Dis. \n                           1, 155\u2013173 (2012).","journal-title":"J. Huntingtons Dis."},{"key":"5125_CR15","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.brainresbull.2012.04.011","volume":"92","author":"SP Brooks","year":"2013","unstructured":"Brooks, S. P. & Dunnett, S. B. Cognitive deficits in animal models of basal ganglia disorders. Brain Res. Bull. \n                           92, 29\u201340 (2013).","journal-title":"Brain Res. Bull."},{"key":"5125_CR16","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/mds.25997","volume":"29","author":"JS Paulsen","year":"2014","unstructured":"Paulsen, J. S. & Long, J. D. Onset of Huntington\u2019s disease: can it be purely cognitive? Mov. Disord. \n                           29, 1342\u20131350 (2014).","journal-title":"Mov. Disord."},{"key":"5125_CR17","doi-asserted-by":"crossref","unstructured":"Begeti, F., Schwab, L. C., Mason, S. L. & Barker, R. A. Hippocampal dysfunction defines disease onset in Huntington\u2019s disease. J. Neurol. Neurosurg. Pschiatry (2016).","DOI":"10.1136\/jnnp-2015-312413"},{"key":"5125_CR18","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1523\/JNEUROSCI.5052-10.2011","volume":"31","author":"SC McQuown","year":"2011","unstructured":"McQuown, S. C. et al. HDAC3 is a critical negative regulator of long-term memory function. J. Neurosci. \n                           31, 764\u2013774 (2011).","journal-title":"J. Neurosci."},{"key":"5125_CR19","doi-asserted-by":"publisher","unstructured":"Malvaez, M. et al. HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner. Proc. Natl Acad Sci USA, doi:10.1073\/pnas.1213364110 (2013).","DOI":"10.1073\/pnas.1213364110"},{"key":"5125_CR20","doi-asserted-by":"publisher","first-page":"13124","DOI":"10.1523\/JNEUROSCI.0914-15.2015","volume":"35","author":"KM Bieszczad","year":"2015","unstructured":"Bieszczad, K. M. et al. Histone deacetylase inhibition via RGFP966 releases the brakes on sensory cortical plasticity and the specificity of memory formation. J. Neurosci. \n                           35, 13124\u201313132 (2015).","journal-title":"J. Neurosci."},{"key":"5125_CR21","doi-asserted-by":"publisher","first-page":"16616","DOI":"10.1038\/srep16616","volume":"5","author":"S Sharma","year":"2015","unstructured":"Sharma, S., Shetty, M. S., Arumugam, T. V. & Sajikumar, S. Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B. Sci. Rep. \n                           5, 16616 (2015).","journal-title":"Sci. Rep."},{"key":"5125_CR22","doi-asserted-by":"crossref","unstructured":"Krishna, K., Behnisch, T. & Sajikumar, S. Inhibition of histone deacetylase 3 restores amyloid-beta oligomer-induced plasticity defects in hippocampal CA1 pyramidal neurons. J. Alzheimers Dis (2016).","DOI":"10.3233\/JAD-150838"},{"key":"5125_CR23","doi-asserted-by":"crossref","unstructured":"Debacker, K. et al. Histone deacetylase complexes promote trinucleotide repeat expansions. PLoS Biol., 10(12), e1001257, 1001210.1001371\/journal.pbio.1001257 (2012).","DOI":"10.1371\/journal.pbio.1001257"},{"key":"5125_CR24","doi-asserted-by":"publisher","first-page":"10324","DOI":"10.1093\/nar\/gks810","volume":"40","author":"A-MM Gannon","year":"2012","unstructured":"Gannon, A.-M. M., Frizzell, A., Healy, E. & Lahue, R. S. MutS\u03b2 and histone deacetylase complexes promote expansions of trinucleotide repeats in human cells. Nucleic Acids Res. \n                           40, 10324\u201310333 (2012).","journal-title":"Nucleic Acids Res."},{"key":"5125_CR25","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng0297-197","volume":"15","author":"L Mangiarini","year":"1997","unstructured":"Mangiarini, L. et al. Instability of highly expanded CAG repeats in mice transgenic for the Huntington\u2019s disease mutation. Nature Genet. \n                           15, 197\u2013200 (1997).","journal-title":"Nature Genet."},{"key":"5125_CR26","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/hmg\/9.17.2539","volume":"9","author":"L Kennedy","year":"2000","unstructured":"Kennedy, L. & Shelbourne, P. F. Dramatic mutation instability in HD mouse striaturm: does polyglutamine load contribute to cell-specific vulnerability in Huntington\u2019s disease? Hum. Mol. Genet. \n                           9, 2539\u20132544 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1752-0509-4-29","volume":"4","author":"J-M Lee","year":"2010","unstructured":"Lee, J.-M. et al. A novel approach to investigate tissue-specific trinucleotide repeat instability. BMC Syst Biol \n                           4, 29\u201344 (2010).","journal-title":"BMC Syst Biol"},{"key":"5125_CR28","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1093\/hmg\/ddg352","volume":"12","author":"L Kennedy","year":"2003","unstructured":"Kennedy, L. et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. Hum. Mol Genet \n                           12, 3359\u20133367 (2003).","journal-title":"Hum. Mol Genet"},{"key":"5125_CR29","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1093\/hmg\/ddm054","volume":"16","author":"PF Shelbourne","year":"2007","unstructured":"Shelbourne, P. F. et al. Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain. Hum. Mol. Genet. \n                           16, 1133\u20131142 (2007).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR30","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1073\/pnas.0800048105","volume":"105","author":"R Gonitel","year":"2008","unstructured":"Gonitel, R. et al. DNA instability in postmitotic neurons. Proc. Natl Acad Sci USA \n                           105, 3467\u20133472 (2008).","journal-title":"Proc. Natl Acad Sci USA"},{"key":"5125_CR31","doi-asserted-by":"publisher","first-page":"e1003280","DOI":"10.1371\/journal.pgen.1003280","volume":"9","author":"S Tome","year":"2013","unstructured":"Tome, S. et al. MSH3 polymorphisms and protein levels affect CAG repeat instability in Huntington\u2019s disease mice. PLoS Genet. \n                           9, e1003280 (2013).","journal-title":"PLoS Genet."},{"key":"5125_CR32","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.nbd.2015.01.004","volume":"76","author":"E Larson","year":"2015","unstructured":"Larson, E., Fyfe, I., Morton, A. J. & Monckton, D. G. Age-, tissue- and length-dependent bidirectional somatic CAG\u2219CTG repeat instability in an allelic series of R6\/2 Huntington disease mice. Neurobiol. Dis. \n                           76, 98\u2013111 (2015).","journal-title":"Neurobiol. Dis."},{"key":"5125_CR33","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/hmg\/ddg056","volume":"12","author":"VC Wheeler","year":"2003","unstructured":"Wheeler, V. C. et al. Mismatch repair gene Msh2 modifies the timing of early disease in HdhQ111 striatum. Hum. Mol. Genet. \n                           12, 273\u2013281 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR34","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1093\/hmg\/ddp242","volume":"18","author":"M Swami","year":"2009","unstructured":"Swami, M. et al. Somatic expansion of the Huntington\u2019s disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum. Mol. Genet. \n                           18, 3039\u20133047 (2009).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR35","doi-asserted-by":"crossref","unstructured":"Kovalenko, M. et al. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington\u2019s disease knock-in mice. PLoS One 7, e44273, doi:44210.41371\/journal.pone.0044273 (2012).","DOI":"10.1371\/journal.pone.0044273"},{"key":"5125_CR36","doi-asserted-by":"crossref","unstructured":"Pinto, R. M. et al. Mismatch repair genes Mlh1 and Mlh3 modify CAG instability in Huntington\u2019s disease mice: genome-wide and candidate approaches. PLoS Genet. 9, e1003930, doi:1003910.1001371\/journal.pgen.1003930 (2013).","DOI":"10.1371\/journal.pgen.1003930"},{"key":"5125_CR37","doi-asserted-by":"publisher","first-page":"e1005267","DOI":"10.1371\/journal.pgen.1005267","volume":"11","author":"H Budworth","year":"2015","unstructured":"Budworth, H. et al. Suppression of somatic expansions delays the onset of pathophysiology in a mouse model of Huntington\u2019s disease. PLoS genetics \n                           11, e1005267 (2015).","journal-title":"PLoS genetics"},{"key":"5125_CR38","doi-asserted-by":"crossref","unstructured":"Holter, S. M. et al. A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington\u2019s disease CAG knock-in mice. PLoS One 8, e80923, doi:80910.81371\/journal.pone.0080923 (2013).","DOI":"10.1371\/journal.pone.0080923"},{"key":"5125_CR39","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1172\/JCI74809","volume":"124","author":"V Brito","year":"2014","unstructured":"Brito, V. et al. Neurotrophin receptor p75(NTR) mediates Huntington\u2019s disease-associated synaptic and memory dysfunction. J. Clin. Invest. \n                           124, 4411\u20134428 (2014).","journal-title":"J. Clin. Invest."},{"key":"5125_CR40","doi-asserted-by":"publisher","first-page":"7265","DOI":"10.1093\/hmg\/ddv426","volume":"24","author":"M Puigdellivol","year":"2015","unstructured":"Puigdellivol, M. et al. A role for Kalirin-7 in corticostriatal synaptic dysfunction in Huntington\u2019s disease. Hum. Mol. Genet. \n                           24, 7265\u20137285 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JHD-160191","volume":"5","author":"E Yhnell","year":"2016","unstructured":"Yhnell, E., Dunnett, S. B. & Brooks, S. P. A longitudinal motor characterisation of the HdhQ111 mouse model of Huntington\u2019s disease. J. Huntingtons Dis. \n                           5, 149\u2013161 (2016).","journal-title":"J. Huntingtons Dis."},{"key":"5125_CR42","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.expneurol.2016.05.008","volume":"282","author":"E Yhnell","year":"2016","unstructured":"Yhnell, E., Lelos, M. J., Dunnett, S. B. & Brooks, S. P. Cognitive training modifies disease symptoms in a mouse model of Huntington\u2019s disease. Exp. Neurol. \n                           282, 19\u201326 (2016).","journal-title":"Exp. Neurol."},{"key":"5125_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jneumeth.2015.08.022","volume":"265","author":"E Yhnell","year":"2016","unstructured":"Yhnell, E., Dunnett, S. B. & Brooks, S. P. The utilisation of operant delayed matching and non-matching to position for probing cognitive flexibility and working memory in mouse models of Huntington\u2019s disease. J. Neurosci. Methods \n                           265, 72\u201380 (2016).","journal-title":"J. Neurosci. Methods"},{"key":"5125_CR44","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s000180050315","volume":"55","author":"W Tischmeyer","year":"1999","unstructured":"Tischmeyer, W. & Grimm, R. Activation of immediate early genes and memory formation. Cell Mol. Life Sci. \n                           55, 564\u2013574 (1999).","journal-title":"Cell Mol. Life Sci."},{"key":"5125_CR45","doi-asserted-by":"publisher","first-page":"6128","DOI":"10.1523\/JNEUROSCI.0296-07.2007","volume":"27","author":"CG Vecsey","year":"2007","unstructured":"Vecsey, C. G. et al. Histone deacetylase inhibitors enhance memory and synaptic plasticity via CREB:CBP-dependent transcriptional activation. J. Neurosci. \n                           27, 6128\u20136140 (2007).","journal-title":"J. Neurosci."},{"key":"5125_CR46","doi-asserted-by":"publisher","first-page":"5776","DOI":"10.1523\/JNEUROSCI.5288-13.2014","volume":"34","author":"A Parra-Damas","year":"2014","unstructured":"Parra-Damas, A. et al. Crtc1 activates a transcriptional program deregulated at early Alzheimer\u2019s disease-related stages. J. Neurosci. \n                           34, 5776\u20135787 (2014).","journal-title":"J. Neurosci."},{"key":"5125_CR47","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.nbd.2004.08.009","volume":"17","author":"A Cybulska-Klosowicz","year":"2004","unstructured":"Cybulska-Klosowicz, A. et al. Impaired learning-dependent cortical plasticity in Huntington\u2019s disease transgenic mice. Neurobiol. Dis. \n                           17, 427\u2013424 (2004).","journal-title":"Neurobiol. Dis."},{"key":"5125_CR48","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1523\/JNEUROSCI.4320-04.2005","volume":"23","author":"NK Mazarakis","year":"2005","unstructured":"Mazarakis, N. K. et al. Deficits in experience-dependent cortical plasticity and sensory-discrimination learning in presymptomatic Huntington\u2019s disease mice. J. neurosci. \n                           23, 3059\u20133066 (2005).","journal-title":"J. neurosci."},{"key":"5125_CR49","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","volume":"120","author":"L Backman","year":"1997","unstructured":"Backman, L., Robins-Wahlin, T. B., Lundin, A., Ginovart, N. & Farde, L. Cognitive deficits in Huntington\u2019s disease are predicted by dopaminergic PET markers and brain volumes. Brain \n                           120, 2207\u20132217 (1997).","journal-title":"Brain"},{"key":"5125_CR50","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1093\/brain\/123.7.1349","volume":"123","author":"AD Lawrence","year":"2000","unstructured":"Lawrence, A. D., Watkins, L. H., Sahakian, B. J., Hodges, J. R. & Robbins, T. W. Visual object and visuospatial cognition in Huntington\u2019s disease: implications for information processing in corticostriatal circuits. Brain \n                           123, 1349\u20131364 (2000).","journal-title":"Brain"},{"key":"5125_CR51","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1016\/S0028-3932(00)00028-2","volume":"38","author":"LH Watkins","year":"2000","unstructured":"Watkins, L. H. et al. Impaired planning but intact decision making in early Huntington\u2019s disease: implications for specific fronto-striatal pathology. Neuropsychologia \n                           38, 1112\u20131125 (2000).","journal-title":"Neuropsychologia"},{"key":"5125_CR52","first-page":"61","volume":"277","author":"M Gomes-Pereira","year":"2004","unstructured":"Gomes-Pereira, M., Bidichandani, S. I. & Monckton, D. G. Analysis of unstable triplet repeats using small-pool polymerase chain reaction. Methods Mol. Biol. \n                           277, 61\u201376 (2004).","journal-title":"Methods Mol. Biol."},{"key":"5125_CR53","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/hmg\/8.1.115","volume":"8","author":"VC Wheeler","year":"1999","unstructured":"Wheeler, V. C. et al. Length-dependent gametic CAG repeat instability in the Huntington\u2019s disease knock-in mice. Hum. Mol. Genet. \n                           8, 115\u2013122 (1999).","journal-title":"Hum. Mol. Genet."},{"key":"5125_CR54","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1098\/rstb.1999.0449","volume":"354","author":"JH Cha","year":"1999","unstructured":"Cha, J. H. et al. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington\u2019s disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. \n                           354, 981\u2013989 (1999).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"5125_CR55","doi-asserted-by":"publisher","first-page":"6809","DOI":"10.1073\/pnas.120166397","volume":"97","author":"JA Bibb","year":"2000","unstructured":"Bibb, J. A. et al. Severe deficiencies in dopamine signaling in presymptomatic Huntington\u2019s disease mice. Proc. Natl Acad Sci USA \n                           97, 6809\u20136814 (2000).","journal-title":"Proc. Natl Acad Sci USA"},{"key":"5125_CR56","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","volume":"97","author":"M Glass","year":"2000","unstructured":"Glass, M., Dragunow, M. & Faull, R. L. The pattern of neurodegeneration in Huntington\u2019s disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington\u2019s disease. Neuroscience \n                           97, 505\u2013519 (2000).","journal-title":"Neuroscience"},{"key":"5125_CR57","doi-asserted-by":"publisher","first-page":"3751","DOI":"10.1097\/00001756-200011270-00032","volume":"11","author":"A van Dellen","year":"2000","unstructured":"van Dellen, A. et al. N-acetylaspartate and DARPP-32 levels decrease in the corpus striatum of Huntington\u2019s disease mice. Neuroreport \n                           11, 3751\u20133757 (2000).","journal-title":"Neuroreport"},{"key":"5125_CR58","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.neuroscience.2003.11.009","volume":"123","author":"AL Hebb","year":"2004","unstructured":"Hebb, A. L., Robertson, H. A. & Denovan-Wright, E. M. Striatal phosphodiesterase mRNA and protein levels are reduced in Huntington\u2019s disease transgenic mice prior to the onset of motor symptoms. Neuroscience \n                           123, 967\u2013981 (2004).","journal-title":"Neuroscience"},{"key":"5125_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12017-013-8219-0","volume":"15","author":"I Villar-Menendez","year":"2013","unstructured":"Villar-Menendez, I. et al. Increased 5-methylcytosine and decreased 5-hydroxymethylcytosie levels are associated with reduced striatal A2AR levels in Huntington\u2019s disease. Neuromolecular Med. \n                           15, 295\u2013309 (2013).","journal-title":"Neuromolecular Med."},{"key":"5125_CR60","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/brain\/awv214","volume":"138","author":"F Niccolini","year":"2015","unstructured":"Niccolini, F. et al. Altered PDE10A expression detectable early before symptomatic onset in Huntington\u2019s disease. Brain \n                           138, 3016\u20133029 (2015).","journal-title":"Brain"},{"key":"5125_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2011.12.013","volume":"238","author":"M Arrasate","year":"2012","unstructured":"Arrasate, M. & Finkbeiner, S. Protein aggregates in Huntington\u2019s disease. Exp. Neurol. \n                           238, 1\u201311 (2012).","journal-title":"Exp. Neurol."},{"key":"5125_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.4161\/pri.1.1.4056","volume":"1","author":"G Hoffner","year":"2007","unstructured":"Hoffner, G., Soues, S. & Djian, P. Aggregation of expanded huntingtin in the brains of patients with Huntington disease. Prion \n                           1, 26\u201331 (2007).","journal-title":"Prion"},{"key":"5125_CR63","doi-asserted-by":"crossref","unstructured":"Moumne, L., Campbell, K., Howland, D., Ouyang, Y. & Bates, G. P. Genetic knock-down of Hdac3 does not modify disease-related phenotypes in a mouse model of Huntington\u2019s disease. PLoS One 7, e31080, doi:31010.31371\/journal.pone.0031080 (2012).","DOI":"10.1371\/journal.pone.0031080"},{"key":"5125_CR64","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1523\/JNEUROSCI.20-11-03993.2000","volume":"20","author":"JF Guzowski","year":"2000","unstructured":"Guzowski, J. F. et al. Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J. Neurosci. \n                           20, 3993\u20134001 (2000).","journal-title":"J. Neurosci."},{"key":"5125_CR65","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3233\/JAD-150975","volume":"51","author":"JP Morin","year":"2016","unstructured":"Morin, J. P. et al. Spatial memory impairment is associated with intraneural amyloid-\u03b2 immunoreactivity and dysfunctional Arc expression in the hippocampal-CA3 region of a transgenic mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. \n                           51, 69\u201379 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"5125_CR66","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/nar\/gkl048","volume":"34","author":"HC Chuang","year":"2006","unstructured":"Chuang, H. C., Chang, C. W., Chang, G. D., Yao, T. P. & Chen, H. Histone deacetylase 3 binds to and regulates the GCMa transcription factor. Nucleic Acids Res. \n                           34, 1459\u20131469 (2006).","journal-title":"Nucleic Acids Res."},{"key":"5125_CR67","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1128\/MCB.00882-06","volume":"27","author":"S Gregoire","year":"2007","unstructured":"Gregoire, S. et al. Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2. Mol. Cell. Biol. \n                           27, 1280\u20131295 (2007).","journal-title":"Mol. Cell. Biol."},{"key":"5125_CR68","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuron.2004.05.021","volume":"42","author":"JM Alarcon","year":"2004","unstructured":"Alarcon, J. M. et al. Chromatin acetylation, memory, and LTP are impaired in CBP+\/\u2212 mice: a model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration. Neuron \n                           42, 947\u2013959 (2004).","journal-title":"Neuron"},{"key":"5125_CR69","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1037\/0735-7044.120.3.724","volume":"120","author":"AM Oliveira","year":"2006","unstructured":"Oliveira, A. M., Abel, T., Brindle, P. K. & Wood, M. A. Differential role for CBP and p300 CREB-binding domain in motor skill learning. Behav. Neurosci. \n                           120, 724\u2013729 (2006).","journal-title":"Behav. Neurosci."},{"key":"5125_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2008.09.014","volume":"33","author":"E Dragileva","year":"2009","unstructured":"Dragileva, E. et al. Intergenerational and striatal CAG repeat instability in Huntington\u2019s disease knock-in mice involve different DNA repair genes. Neurobiol. Dis. \n                           33, 37\u201347 (2009).","journal-title":"Neurobiol. Dis."},{"key":"5125_CR71","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/70598","volume":"23","author":"K Manley","year":"1999","unstructured":"Manley, K., Shirley, T. L., Flaherty, L. & Messer, A. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice. Nat. Genet. \n                           23, 471\u2013473 (1999).","journal-title":"Nat. Genet."},{"key":"5125_CR72","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/86906","volume":"27","author":"IV Kovtun","year":"2001","unstructured":"Kovtun, I. V. & McMurray, C. T. Trinucleotide expansion in haploid germ cells by gap repair. Nat. Genet. \n                           27, 407\u2013411 (2001).","journal-title":"Nat. Genet."},{"key":"5125_CR73","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s00439-006-0164-7","volume":"119","author":"L Foiry","year":"2006","unstructured":"Foiry, L. et al. Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice. Hum. Genet. \n                           119, 520\u2013526 (2006).","journal-title":"Hum. Genet."},{"key":"5125_CR74","doi-asserted-by":"publisher","first-page":"10144","DOI":"10.1073\/pnas.94.19.10144","volume":"94","author":"JT Drummond","year":"1997","unstructured":"Drummond, J. T., Genschel, J., Wolf, E. & Modrich, E. DHFR\/MSH3 amplification in methotrexate-resistant cells alters the hMutSalpha\/hMutSbeta ratio and reduces the efficiency of base-base mismatch repair. Proc. Natl. Acad. Sci. \n                           94, 10144\u201310149 (1997).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"5125_CR75","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JHD-2012-129004","volume":"1","author":"EM Sontag","year":"2012","unstructured":"Sontag, E. M. et al. Detection of Mutant Huntingtin Aggregation Conformers and Modulation of SDS-Soluble Fibrillar Oligomers by Small. Molecules. J. Huntingtons Dis. \n                           1, 119\u2013132 (2012).","journal-title":"Molecules. J. Huntingtons Dis."},{"key":"5125_CR76","doi-asserted-by":"publisher","first-page":"16017","DOI":"10.1074\/jbc.M111.252577","volume":"287","author":"LG Nucifora","year":"2012","unstructured":"Nucifora, L. G. et al. Identification of novel potentially toxic oligomers formed in vitro from mammalian-derived expanded huntingtin exon-1 protein. J. Biol. Chem. \n                           287, 16017\u201316028 (2012).","journal-title":"J. Biol. Chem."},{"key":"5125_CR77","doi-asserted-by":"publisher","first-page":"e76842","DOI":"10.1371\/journal.pone.0076842","volume":"8","author":"S Chandwani","year":"2013","unstructured":"Chandwani, S. et al. Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2. PLoS One \n                           8, e76842 (2013).","journal-title":"PLoS One"},{"key":"5125_CR78","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.celrep.2012.10.001","volume":"2","author":"Z Xun","year":"2012","unstructured":"Xun, Z. et al. Targeting of XJB-5-131 to mitochondria suppresses oxidative DNA damage and motor decline in a mouse model of Huntington\u2019s disease. Cell Reports \n                           2, 1137\u20131142 (2012).","journal-title":"Cell Reports"},{"key":"5125_CR79","doi-asserted-by":"crossref","unstructured":"Lloret, A. et al. Genetic background modifies nuclear mutant huntingtin accumulation and HD CAG repeat instability in Huntington\u2019s disease knock-in mice. Hum. Mol. Genet. 15 (2006).","DOI":"10.1093\/hmg\/ddl125"},{"key":"5125_CR80","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1002\/hipo.22128","volume":"23","author":"A Giralt","year":"2013","unstructured":"Giralt, A. et al. PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington\u2019s disease mouse model. Hippocampus \n                           23, 684\u2013695 (2013).","journal-title":"Hippocampus"},{"key":"5125_CR81","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1093\/hmg\/9.19.2799","volume":"9","author":"F Trettel","year":"2000","unstructured":"Trettel, F. et al. Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells. Hum. Mol. Genet. \n                           9, 2799\u20132809 (2000).","journal-title":"Hum. Mol. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05125-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05125-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T02:16:34Z","timestamp":1671761794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-05125-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":81,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["5125"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-05125-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,20]]},"assertion":[{"value":"19 January 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6082"}}